News

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}
Welcome to our Corporate client solution

Here you can administrate your corporate solutions users.
Welcome to your subscription for Life Science Focus
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Focus.

Click here to go to sign-up

Advertisement

Advertisement

FDA turns down Novocure’s brain metastases device

Gubra CEO steps down with immediate effect

In Focus

From IV drips to injection pens: Why more drugs can be given under the skin

FDA approves Bayer’s first-in-class stroke drug

Danish biotech company raises €20 million: Closing in on clinical trials

Advertisement

Trump's drug policy linked to fewer launches in Europe

In Focus

Autoinjectors gain ground across therapeutic areas: “A huge trend”

Oncopeptides secures broader EU indication for Pepaxti

In Focus

EU Biotech Act's lead negotiator: “It's now or never”

Sponsored content News from our members

Cavidi AB

Cavidi’s BOLD Named “Proteomics Innovation of the Year” as US Patent Nears Grant

AxFlow AB

Process equipment for biotechnology and pharmaceutical production

Strömberg Distribution Sverige

3PL- där kvalitet aldrig kompromissas

Aurevia

UK plans permanent recognition of CE-marked medical devices

OEM Automatic AB

Rätt ledare för rätt kabelapplikation

Aurevia

Upcoming Course: Internal Audits Based on ISO 13485 for Medtech Organizations

GRUBER A/S

Gruber delivers technology for demanding production environments

Aurevia

From legacy devices to software IVDs: Medtech Compliance Forum puts the spotlight on IVDR compliance

OEM Automatic AB

Rätt ventil för rätt applikation – hitta lösningen hos OEM Automatic

SGS Fimko

Structured Dialogue with SGS Fimko – a clearer path through MDR and IVDR

GRUBER A/S

GRUBER aims to eliminate bottlenecks in pharmaceutical production

Aurevia

What if some of the most influential systems in healthcare are the least regulated?

See all announcements

Sponsored content

30 Years of Connecting Medicon Valley

Advertisement

EFN: Could AstraZeneca make a move for Sobi?

Zolgensma gene therapy under investigation after tumour reports

In Focus

Early gene therapy offers hope for some ALS patients

Advertisement

Column

Catharina Barkman: Health gains that transform lives and economies

Bleeding in newborns nearly quadruples as more parents refuse vitamin K

Advertisement

Gubra seeks to double number of candidates in 2030

Advertisement

Advertisement

In Focus

Labour drug shortage in Sweden could be fixed by looking towards Denmark

Interview

“That’s how it is in biotech – there are ups and downs”

Updated: Egetis receives SEK 5.3 billion takeover bid from US company

Advertisement

Boehringer doubles down on China with $7.4 billion deal

People & Careers

Takes on new CEO role as Aqilion winds down its operations

Pharmaceutical executives play down AI hype – see no quick path to cures

Advertisement

Sources: AstraZeneca bid $10 billion for Rhythm Pharmaceuticals

Advertisement

Yes please, I would like to receive Life Science Focuss newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Focus Read cookie and data policy.

Newsletter

Life Science Focus Breaking/Extra

Advertisement Advertisement

BREAKING

{{ article.headline }}

0.062|